Hydrocobamine

Quick links to important sections

Hydrocobamine

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Hydrocobamine

Property Description
Active ingredient Hydroxocobalamin
Form Solution for injection (Aqueous)
Pharmacological class B vitamin, Anti-anemic drug
Common use Prevention/treatment of Vitamin B12 deficiency
Origin Manufactured substance

Hydrocobamine is a prescription-only medicinal preparation whose active compound is Hydroxocobalamin, which is the International Nonproprietary Name (INN) for a specific form of Vitamin B12. It is fundamentally classified as an anti-anemic drug and a Cobalamin derivative belonging to the B vitamin complex, essential for human function. Hydroxocobalamin is recognized as an essential medicine for the treatment of megaloblastic anemia due to B12 deficiency.


What Type of Essential Nutrient is Hydrocobamine?

Hydroxocobalamin is categorized as an essential water-soluble vitamin precursor, required for health but quickly converted by the body into its two metabolically active forms to be effective. This conversion is necessary because these active cofactors are vital for processes like DNA synthesis and maintaining the health of nerve cells. Chemically, Hydroxocobalamin is considered structurally closer to the B12 forms naturally found in food than is the common analogue Cyanocobalamin.


Composition, Origin, and Primary Forms

The Hydrocobamine preparation is a single-ingredient drug composed of the Hydroxocobalamin active ingredient, often utilized as a sterile aqueous solution for injection. The primary dosage form is an injectable solution (for intramuscular or intravenous administration). This injectable route is recognized as an effective delivery method for ensuring reliable absorption, particularly for adult patients diagnosed with conditions that cause poor absorption of oral B12 through the digestive tract. The injectable route serves to bypass common B12 malabsorption issues.


What is the General Purpose of Hydroxocobalamin?

The general purpose of providing Hydroxocobalamin is to support vital metabolic and cellular processes, most notably ensuring the healthy production of red blood cells. By supplying this necessary B vitamin, the compound supports hematopoiesis, thus helping to prevent the severe macrocytic anemia that results from chronic deficiency. Furthermore, the substance serves a specialized, critical function in emergency medicine, acting as a binding agent to neutralize specific toxins in cases of acute cyanide poisoning.

Regulatory References

  1. WHO Essential Medicines List

What side effects are possible with Hydrocobamine?

Possible Side Effects and Safety Information

The official safety profile for Hydroxocobalamin, the active ingredient in Hydrocobamine, lists potential adverse reactions across various System-Organ Classes, as documented in regulatory sources.

Frequency and System Classification

Adverse effects are categorized based on incidence, with some reactions classified as Very Common (affecting more than 1 in 10 patients) or of Not Known frequency (frequency cannot be estimated from available data, often reflecting post-marketing reports).

Very Common reactions noted in official labeling include chromaturia (red-colored urine), which can last for weeks; erythema (skin redness); headache; and transient increases in blood pressure. Injection site reactions are also officially noted as common.

Reactions classified as Not Known include generalized hypersensitivity reactions, such as rash and itching, and certain cardiovascular events like arrhythmias secondary to hypokalaemia (low potassium), which may occur at the beginning of parenteral treatment.

Serious Adverse Reactions and Safety Constraints

Regulatory documents highlight the potential for serious adverse reactions, including anaphylaxis (a severe allergic reaction) and rare reports of acute renal failure. Specific warnings address the possibility of congestive heart failure and pulmonary oedema reported during the initial intensive treatment phase of severe anemia.

Certain constraints are also documented. The deep red color of Hydroxocobalamin interferes with the colorimetric determination of several clinical laboratory tests. Furthermore, the official label notes that the use of this medicine may mask the true diagnosis of folate deficiency, as adequate hematologic response may be produced in such cases.

Overdose and Emergency Response

Overdose and when to seek help

The information regarding overdose of Hydrocobamine (Hydroxocobalamin injection) is strictly defined by regulatory authorities and reflects its profile as a water-soluble B vitamin.

Documented Overdose Manifestations

Official prescribing information for the anti-anemic formulation does not list specific signs or symptoms of toxicity resulting from overdose, as the substance is rapidly eliminated by the body. Consequently, no amount of Hydroxocobalamin is officially defined as leading to a classic toxic overdose syndrome. A frequently observed physiological change is chromaturia, which causes a reddish discoloration of the urine, but this is a documented effect of excretion, not a sign of toxicity.

Official Emergency Actions and Management

Despite the low toxicological concern, regulatory guidelines universally mandate that immediate medical attention must be sought in the event of any suspected overdose exposure. This instruction aligns with standard emergency protocols for all administered medications. Management is symptomatic and supportive, consistent with the lack of known toxicity.

Management Aspect Official Regulatory Statement
Toxicity Level Treatment is officially stated to be unlikely to be required
Antidote No specific antidote is known
Required Action Seek immediate medical attention for suspected exposure

The overall regulatory profile confirms that while the risk of severe outcome is low, urgent medical care is required for evaluation whenever excess Hydrocobalamin has been administered.

Therapeutic Uses of Hydrocobamine

What Hydroxocobalamine Treats: Main Uses and Benefits

Hydroxocobamine plays a role in managing low levels of Vitamin B12 in the body. It is commonly used to help manage symptoms of deficiency, particularly those related to pernicious anemia or malabsorption. This medication is applied across therapeutic domains involving certain distressing symptoms, including those associated with severe fatigue and weakness, numbness and tingling, and breathing difficulties.

This supportive therapy may help manage symptoms that create noticeable functional strain in individuals with conditions characterized by periods of heightened symptoms (like chronic malabsorption) that interfere with routine activities. It is relevant when supportive symptom management is appropriate and contributes to improved comfort during symptomatic periods.

“This medication is applied across therapeutic domains involving certain distressing symptoms.”

Quick Fact: Support for Fatigue and Neurological Symptoms

Hydroxocobamine may assist with managing symptoms related to physical discomfort and supports general well-being during symptomatic phases, addressing manifestations such as extreme tiredness and nerve discomfort.

Eligibility and Restrictions for Use

Who can and cannot use Hydrocobamine?

Eligibility for Hydrocobamine (Hydroxocobalamin injection) is defined by official regulatory documents based on patient status, age, and pre-existing conditions.

Contraindications

Use is strictly prohibited (contraindicated) for individuals with a known hypersensitivity to hydroxocobalamin or to cobalt, a component element of the drug substance. Additionally, the medicine must not be administered intravenously when treating Vitamin B12 deficiency, as the injectable route is mandated as intramuscular.

Age and Population Eligibility

Hydrocobamine is officially indicated for use across major age groups, including adults, children, and adolescents, for the management of Vitamin B12 deficiency. Studies have not demonstrated specific problems that limit its use in older adults. However, specific injectable formulations may be not recommended for infants due to the presence of certain inactive ingredients.

Restricted and Conditional Use

Certain conditions require careful medical consideration and monitoring. Patients with pre-existing heart problems, kidney or liver issues, or those at risk of hypokalemia (low potassium) during initial treatment fall into this category. For women who are pregnant, use is often restricted and requires confirmation of a Vitamin B12 deficiency; however, use during breastfeeding is generally permitted as the substance is considered unlikely to harm the infant.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Hydroxocobalamin, the active ingredient in Hydrocobamine, has officially documented interaction patterns that are focused on alterations to its effectiveness or blood concentration, as described in government regulatory labeling. The full scope of interaction studies for the injectable preparation is often noted to have only been performed in adults.

Documented Pharmacological Interactions

Interacting Product Official Interaction Statement
Chloramphenicol Co-administration may attenuate the therapeutic effect of Hydroxocobalamin in anemia.
Oral Contraceptives Use may result in lowering of Hydroxocobalamin serum concentrations (a pharmacokinetic effect).
Folic Acid (high dose) May mask the hematologic symptoms of B12 deficiency, which risks allowing neurological damage to progress.

Administration Context and Contraindications

No drug–drug combinations are formally classified as contraindicated in the regulatory documents for B12 deficiency treatment. Furthermore, official guidance states that no specific dietary restrictions or avoidance of alcohol is required with the injectable preparation. This approach ensures consistent delivery of the medicine, bypassing common gastrointestinal malabsorption issues.

Mechanism of Action

Enabling DNA Synthesis and Myelin Protection via Cofactor Supply

Hydroxocobalamin, a cobalamin precursor, must first undergo conversion into its active cofactors, Methylcobalamin and Adenosylcobalamin. These cofactors are crucial for two enzymatic reactions: one that frees up the necessary ingredients for DNA synthesis (via the Methionine cycle), and another that regulates the buildup of neurotoxic metabolites (Methylmalonic acid) in the nervous system. This mechanism supports the maturation of red blood cell precursors and maintains the structural integrity of the neuronal myelin sheath.


️ Mechanism of Direct Chemical Toxin Scavenging

The drug has a distinct secondary mechanism that involves a rapid, high-affinity chemical interaction with free cyanide ions ( CN^-). By directly binding the toxin, Hydroxocobalamin forms a non-toxic compound that is safely excreted, thereby interfering with cyanide's inhibition of cellular respiration. This mechanism, by rapidly removing the toxin, enables the cell's capacity to utilize oxygen.

Dosage and Administration Information

Hydroxocobalamin administration is dictated by the condition being treated, following two distinct routes and dosage protocols.

Administration for Vitamin B12 Deficiency

Feature Protocol (Intramuscular Injection)
Route of Administration Intramuscular (IM) injection only. The intravenous route is to be avoided for this indication.
Dosing Initial: 30 mu g to 1000 mu g administered daily or every other day for 5 to 10 days. Maintenance: 100 mu g to 200 mu g monthly, or 1000 mu g every 2 to 3 months, depending on the specific deficiency and patient condition.
Age-Group Rules Dosing schemes are generally suitable for adults and children, with pediatric maintenance doses often falling between 30 mu g and 50 mu g every 4 weeks after the initial regimen.
Special Conditions Therapy is typically required for the remainder of the patient's life for conditions like Addisonian Pernicious Anemia; oral therapy is not a dependable substitute.

Administration for Acute Cyanide Poisoning

Feature Protocol (Intravenous Infusion)
Route of Administration Intravenous (IV) infusion administered rapidly.
Dosing Adult Starting Dose: 5 g infused over 15 minutes. Second Dose: An additional 5 g may be administered via IV infusion, with an infusion rate ranging from 15 minutes to 2 hours, not to exceed a total dose of 10 g.
Preparation The lyophilized powder must be reconstituted with 200 mL of diluent (0.9% Sodium Chloride is recommended). The vial must be repeatedly inverted or rocked, not shaken, for at least 60 seconds.
Special Conditions Must be administered via a separate intravenous line; simultaneous administration with sodium thiosulfate, sodium nitrite, or blood products in the same line is chemically incompatible and not recommended.

The structure of the instructions clearly separates the long-term, scheduled, low-dose intramuscular regimen for nutritional deficiencies from the high-dose, rapid intravenous infusion protocol used as an emergency antidote. The procedural steps include specific rules for injection route, powder reconstitution, and co-administration constraints to ensure proper use based on the indication.

Recent Clinical Evidence

Hydrocobamine: Recent Clinical Evidence

Evidence for use in Vitamin B12 Deficiency and Megaloblastic Anemia

Research has explored how Hydrocobamine was studied for conditions such as Vitamin B12 deficiency and megaloblastic anemia. The research primarily consisted of controlled studies, including short-term randomized controlled trials (RCTs). These studies monitored changes in blood cell counts and specific outcomes related to systemic imbalance, such as levels of B12 and related markers. Findings describe patterns observed in studies where individuals with diagnosed deficiency showed changes in these parameters. Research also examined how symptoms evolved, and some reports described measurements related to physical discomfort during the study period. However, evidence is limited when looking at the overall effect on complex cognitive function, and long-term effects are not fully established.

Evidence for use in Acute Cyanide Poisoning

Because this is a critical, life-threatening situation, research was observed in a different context, focusing on conditions associated with acute or disruptive episodes. The research relied on controlled studies in animal models and observational settings evaluating outcomes in human patients who were hospitalized. Animal studies observed patterns related to survival when exposure to cyanide was chemically induced. Research describes the compound's property of binding to cyanide. Observational reports in humans documented survival status and described changes in severe physiological markers in these individuals. However, the data are still emerging, and there is a lack of direct evidence from controlled human RCTs.

Long-term Studies, Special Populations, and Research Uncertainty

Research has generally involved short-term studies, providing insight into short-term changes in blood parameters. Because follow-up durations were limited, there is limited information for long-term outcomes regarding the study of sustained functional and neurological outcomes. Research examined the outcomes of administration in different populations, including subclinical deficiency and older adults, where findings were mixed regarding cognitive improvement. One key area where certainty remains low is the link between changes in blood markers and actual, lasting neurological improvement. Comparative evidence is lacking in some areas, and the evidence quality varies across studies overall.

Key Studies & References

  1. WHO Model List of Essential Medicines for Megaloblastic Anemia

Frequently Asked Questions (FAQ)

Common questions about Hydrocobamine (FAQ)

Q: What is the main difference between Hydrocobamine and other similar vitamins or supplements?

Hydrocobamine contains Hydroxocobalamin, which is chemically structured more closely to the B12 forms naturally found in food compared to the common analogue, Cyanocobalamin. The injectable form is officially described as ensuring reliable absorption, which is often preferred for people with conditions that result in poor B12 uptake in the digestive system.

Q: How quickly can a person generally expect to feel the effects of Hydrocobamine?

Regulatory labels state that the official timing focuses on the body's internal, biological response. Signs of red blood cell production, called reticulocyte counts, typically begin to show improvement within three to ten days after therapy begins. Official documents do not precisely define the onset of subjective, symptomatic relief.

Q: Does Hydrocobamine cause drowsiness or affect the ability to drive or operate machinery?

Official safety documents have reported dizziness and headache as potential side effects. Regulatory guidance advises that, in general, if side effects like dizziness or feeling unwell occur, operating machinery or driving should be avoided until the feeling has passed.

Q: Is it normal to feel a mild flush or tingling sensation after taking Hydrocobamine?

Official safety compilations report erythema (skin redness or flushing) as a very common side effect, particularly when higher doses are administered. Tingling in the hands or feet has also been reported in compiled side effect data from official sources.

Q: Are there any known long-term side effects associated with the described use of Hydrocobamine?

Official documentation notes that long-term use has been associated with reports of thrombocytosis (an increase in platelets) and potential photosensitivity (increased sensitivity to sunlight). Official documents indicate that there is limited data on long-term outcomes for sustained neurological function.

Q: Can Hydrocobamine interact with common pain relievers like ibuprofen or acetaminophen?

Regulatory sources in some jurisdictions indicate that Hydrocobamine (Hydroxocobalamin) does not typically have documented interactions with many common medicines, including most non-prescription painkillers. It is standard practice to ensure that the prescribing professional is aware of all over-the-counter drugs being used.

Q: Does Hydrocobamine interact with common herbal supplements?

Official regulatory sources are generally focused on drug-to-drug interactions. These sources state that there is not enough specific information to definitively confirm the safety of combining complementary medicines, herbal remedies, and general supplements with Hydrocobamine.

Q: What is the safety classification of Hydrocobamine?

Hydrocobamine is officially classified as a prescription-only medicine in its injectable form. Furthermore, the World Health Organization includes its active ingredient on the List of Essential Medicines used for the treatment of megaloblastic anemia.

Q: Is Hydrocobamine gluten-free, lactose-free, or suitable for vegans?

Official labels list all active and inactive ingredients to define the composition of the product. Information regarding suitability for vegan or other specialized dietary statuses, such as gluten or lactose content, is dependent on reviewing the specific formulation's inactive ingredients.

Q: What does official guidance say about stopping the use of Hydrocobamine?

Official guidance notes that for conditions like Pernicious Anemia, treatment is typically required for the remainder of the patient's life. For reversible deficiencies, the decision to stop therapy is officially contingent upon the underlying cause being resolved and laboratory tests confirming hematologic improvement.

Q: Are there any known interactions between Hydrocobamine and common blood pressure medications?

Official documents note that Hydrocobamine may cause transient increases in blood pressure, and patients with pre-existing heart conditions are noted as requiring careful medical monitoring. No specific drug-drug interaction with common blood pressure medications is universally listed in core labels.

Q: What are the official guidelines regarding the duration of use for Hydrocobamine?

The required duration of use is defined by the underlying medical condition. For certain lifelong deficiencies (like Pernicious Anemia), continuous therapy is officially required for the remainder of the patient's life. For acute management of deficiency, the guidance is divided into an initial intensive treatment phase followed by a periodic maintenance phase.

Q: Does Hydrocobamine have different forms (e.g., tablet, injection, nasal spray), and are they used for different things?

Hydrocobamine is specifically an injectable solution. While there are other forms of Vitamin B12 (such as Cyanocobalamin) that are available as oral tablets or nasal sprays, Hydroxocobalamin is primarily administered via injection. The nasal spray form, where available, is often used for maintenance therapy once levels have been normalized.

Q: What if someone experiences an allergic reaction to Hydrocobamine?

Regulatory warnings highlight the potential for severe allergic reactions, including anaphylaxis. Official guidance states that if symptoms such as a rash, persistent itching, difficulty breathing, or swelling of the face, lips, or throat occur, medical attention is required.

Q: Are there any restrictions on professional activities, like heavy machinery operation, while using Hydrocobamine?

While there are no specific blanket restrictions universally mandated, official guidance advises caution. In the event side effects such as dizziness or severe headache are experienced, activities like driving or operating heavy machinery should be avoided until these effects have passed.

Q: Is it described in official sources that Hydrocobamine helps with 'energy levels'?

Official documents primarily define the purpose of Hydrocobamine as correcting anemia and supporting hematopoiesis (the healthy production of blood cells). Individuals with a severe B12 deficiency and resulting anemia have been described as experiencing an improvement in symptoms potentially related to energy levels once the underlying anemia is corrected.

Q: Can Hydrocobamine be taken on an empty stomach?

The question of an empty stomach is not relevant for this medicine. Hydrocobamine is an injectable solution administered directly into the muscle or vein. Because it bypasses the digestive system entirely, the presence or absence of food in the stomach does not impact its absorption or effectiveness.

Q: Is Hydrocobamine available under different brand names, and are they the same?

Yes, Hydroxocobalamin is the official non-proprietary name for the active ingredient. Official regulatory sources list the drug substance as being sold under various brand names, such as Cobalin-H or Neo-Cytamen, depending on the country.

Q: What does the research say about Hydrocobamine for people with specific dietary restrictions?

Official product information notes that B12 deficiency can commonly affect people with certain dietary restrictions, such as strict vegetarians, as B12 is mainly found in animal products. For these groups, the injectable form of Hydroxocobalamin is indicated as the standard treatment to reliably manage the deficiency.

Q: Why do some people need to use Hydrocobamine for a long time?

The requirement for lifelong therapy is linked to specific underlying medical conditions, most notably Pernicious Anemia. This condition causes the body to fail to produce Intrinsic Factor, which is the substance required for B12 to be absorbed through the gut. In such cases, long-term injections are needed to bypass the absorption problem.

Q: Does Hydrocobamine contain any known allergens?

Official contraindications state that the medicine must not be used in individuals with a known hypersensitivity to Hydroxocobalamin itself or to cobalt, a component element of the drug substance. This guidance ensures patients with these allergies are strictly excluded from treatment.

Q: What happens to Hydrocobamine when it is no longer needed by the body?

According to official clinical pharmacology data, Hydroxocobalamin is primarily bound to plasma proteins and stored in the liver. Any amount not stored is eliminated from the body via excretion in the bile and urine. A large percentage of the dose (up to 66%) may be found in the urine, with the major portion being excreted within the first day of administration.

Q: Can Hydrocobamine be used alongside dietary modifications for the same condition?

Official guidance often reinforces the need to manage the underlying cause of the deficiency. Therefore, regulatory sources for this and related B12 forms advise patients to continue to carefully follow their healthcare provider's instructions about diet and the use of oral supplements alongside the injectable therapy.

Q: Are there any common reasons why Hydrocobamine might be ineffective for some people?

Official documents highlight that certain drug interactions, such as concomitant use of Chloramphenicol, may reduce the therapeutic effect. The use of high doses of Folic Acid is also noted as potentially masking the blood symptoms of the deficiency. Research indicates that findings of efficacy were mixed in certain special populations, which may relate to the overall patient response.

How should Hydrocobamine be stored and disposed of?

Official Storage and Disposal Requirements

Hydroxocobalamin must be stored according to specific regulatory requirements to maintain its stability. Store the medicine at or below 25^\circC, or do not store above 30^\circC. It is critical to Protect from light by keeping the medicine in its original pack or outer carton.

Do not freeze the product.

Keep the medicine strictly out of the reach of children, ideally in a locked cupboard. Do not store the medicine in environments such as the bathroom or near a sink.

For products that require reconstitution (mixing), any solution that is not used within its mandated stability period—for example, within 6 hours—must be discarded. Used or contaminated hypodermic needles and syringes must be placed into a rigid "Sharps" container. Unused or expired medicine should be returned to any pharmacy for safe and compliant disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Hydrocobamine found in:

A-Z Index: